CAELYX

This brand name is authorized in Austria, Australia, Brazil, Canada, Cyprus, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Lithuania, Nigeria, Netherlands, New Zealand, Poland, Romania, Singapore, Turkey, United Kingdom, South Africa

Active ingredients

The drug CAELYX contains one active pharmaceutical ingredient (API):

1 Doxorubicin UNII 82F2G7BL4E - DOXORUBICIN HYDROCHLORIDE

Doxorubicin is a cytotoxic anthracycline antibiotic obtained from Streptomyces peucetius var. caesius. The exact mechanism of the antitumour activity of doxorubicin is not known. It is generally believed that inhibition of DNA, RNA and protein synthesis is responsible for the majority of the cytotoxic effects. Read about Doxorubicin

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
CAELYX Concentrate for solution for infusion	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
L01DB01	Doxorubicin	L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01D Cytotoxic antibiotics and related substances → L01DB Anthracyclines and related substances
Discover more medicines within L01DB01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 4364Q, 5705G, 6249X, 7230M
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 514508301159310, 514515100028103
Country: CA	Health Products and Food Branch	Identifier(s): 02238389
Country: EE	Ravimiamet	Identifier(s): 1139554, 1139565, 1213221, 1213232
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 96011001
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 066111
Country: FR	Base de données publique des médicaments	Identifier(s): 62362369
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 204719, 204724, 392345
Country: HK	Department of Health Drug Office	Identifier(s): 43397, 66647
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 7295
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1015575, 1015576, 1028060, 1028061, 1055646
Country: NG	Registered Drug Product Database	Identifier(s): B4-8252
Country: NL	Z-Index G-Standaard	Identifier(s): 14175126, 14633620
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 50008, 58734
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 7732
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100112718
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W67977001, W67977002, W67977003, W67977004
Country: SG	Health Sciences Authority	Identifier(s): 10426P
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8681413881435
Country: ZA	Health Products Regulatory Authority	Identifier(s): 32/26/0533